Y-mAbs Therapeutics Inc.

6.18
-0.01 (-0.16%)
At close: Jan 22, 2025, 3:59 PM
6.19
0.08%
After-hours Jan 22, 2025, 04:41 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 84.82M 65.27M 34.90M 20.75M n/a n/a n/a n/a
Cost of Revenue 11.42M 7.57M 2.51M 2.20M 166.00K 29.00K n/a n/a
Gross Profit 73.40M 57.70M 32.38M 18.55M -166.00K -29.00K n/a n/a
Operating Income -25.67M -94.81M -115.43M -119.94M -83.00M -43.23M -19.24M -17.04M
Interest Income n/a 643.00K 1.85M 598.00K 1.98M n/a n/a n/a
Pretax Income -20.87M -95.57M -55.27M -119.34M -81.03M -43.27M -19.16M -17.06M
Net Income -21.43M -96.33M -56.34M -118.34M -78.89M -43.27M -19.16M -17.06M
Selling & General & Admin 44.86M 60.94M 54.57M 44.78M 19.51M 8.96M 4.94M 3.18M
Research & Development 54.22M 91.57M 93.25M 93.70M 63.49M 34.27M 14.31M 13.86M
Other Expenses n/a n/a 62.01M -2.20M n/a -44.00K 83.00K -18.00K
Operating Expenses 99.08M 152.51M 147.82M 138.48M 83.00M 43.23M 19.24M 17.04M
Interest Expense n/a 757.00K 1.85M 598.00K 1.98M n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 110.49M 160.08M 150.33M 138.48M 83.00M 43.23M 19.24M 17.04M
Income Tax 561.00K 757.00K 1.07M -994.00K -2.14M -44.00K -19.24M -17.04M
Shares Outstanding (Basic) 43.65M 43.70M 43.18M 40.12M 35.18M 28.77M 33.29M 33.29M
Shares Outstanding (Diluted) 43.65M 43.70M 43.18M 40.12M 35.18M 28.77M 33.29M 33.29M
EPS (Basic) -0.49 -2.2 -1.3 -2.95 -2.24 -1.5 -0.58 -0.51
EPS (Diluted) -0.49 -2.2 -1.3 -2.95 -2.24 -1.5 -0.58 -0.51
EBITDA -24.94M -94.73M -54.49M -119.54M -82.84M -43.20M 83.00K -18.00K
Depreciation & Amortization 735.00K 839.00K 782.00K 396.00K 166.00K 29.00K 19.24M 17.04M

Create Price Alert on YMAB

Your price alert will notify you when the stock price is above 6.18.

Add to Watchlist